| |
|
|
|
Acelrx Pharmaceutica  
|
|
2.28 -0.12 (-0.05%) |
01-27 16:00 |
|
Open: |
2.23 |
Pre close: |
2.4 |
Target:
|
3.43
|
|
High: |
2.59 |
Low: |
2.13 |
Resistance:
|
2.94
3.43
|
|
Volume: |
12,184,435 |
Market Cap: |
259M |
Support:
|
1.84
1.16
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.18
 |
MACD |
MACD(12,26):
|
0.24 |
|
MA(20): |
1.75 |
Signal(12,26,9): |
0.17 |
|
MA(100): |
1.55 |
Stochastic Oscillator |
%K(14,3):
|
65.85 |
|
MA(250): |
1.41 |
%D(3): |
58.64 |
|
Average Volume(K) |
3-Month: |
443320
|
52-Week |
High:
|
2.94 |
|
10-Days: |
1601254 |
Low: |
0.70 |
|
RSI |
RSI(14):
|
63.39  |
Change(%): |
32.6 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.559 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
90.48 |
|
EPS Est. Current Year |
-1.120 |
Return on Assets (ttm) |
-34.1 |
Shares Float (M) |
88.61 |
|
EPS Est. Next Year |
-0.940 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.11 |
|
EPS Est. Next Quarter |
-0.230 |
Qtrly Rev. Growth |
125.0 |
% Held by Institutions |
26.93 |
|
Forward EPS |
-0.810 |
Gross Profit (p.s.) |
-0.101 |
Shares Short (K) |
7750 |
|
Book Value (p.s.) |
-0.640 |
EBITDA (p.s.) |
-0.494 |
P/E |
-4.08 |
|
Sales Per Share |
0.057 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-3.56 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-46.33 |
P/S |
40.06 |
|
Operating Margin |
-906.48 |
Levered Free Cash Flow
(M) |
-26.52 |
P/CF |
-4.45 |
|
|
|
|
|
|
